A clinical trial to evaluate the effect of jalaukavacharana in increased d-dimer laboratory values

Dr Nikita Saxena0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1.Patients those have increased D-dimer values in Deep vein thrombosis (DVT), Disseminated intravascular coagulation, Hepatomegaly and Post convalescence SARS Covid-19 patients(after 3 months)will be selected for study.
•2.Participants of any gender in between 16 to 70 ages.
•3.Participants who are willing for the study.

•1.Absolute Hemophiliac and other bleeding disorders.
•2.Anticoagulant medicines like Warfarin, Heparin, etc.
•3.Severe Anemia.
•4.Erosive Gastritis and potential gastrointestinal bleeding.
•5.During Chemotherapy.
•6.Individuals with HIV infection.
•7.Severe Allergic Diathesis (allergy foreign proteins).
•8.Hypotension
•9.Active Tuberculosis.
•10.Pregnancy
•11.Mental disorders during acute episodes.
•12.Severe ill and bed patient.
•13.Acute DVT
•14.Pulmonary Embolism
•15.Malignancy
•16.Participants who are known cases of renal failure, neurological, Diagnosed with CA, and also with psychological disturbances.
•17.Uncontrolled systemic conditions like Diabetes mellitus.
•18.Cirrhosis of the Liver
•19.Coagulopathies.

发起方

Dr Nikita Saxena